Cargando…
Methods for the Drug Effectiveness Review Project
The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532217/ https://www.ncbi.nlm.nih.gov/pubmed/22970848 http://dx.doi.org/10.1186/1471-2288-12-140 |
_version_ | 1782254275240394752 |
---|---|
author | McDonagh, Marian S Jonas, Daniel E Gartlehner, Gerald Little, Alison Peterson, Kim Carson, Susan Gibson, Mark Helfand, Mark |
author_facet | McDonagh, Marian S Jonas, Daniel E Gartlehner, Gerald Little, Alison Peterson, Kim Carson, Susan Gibson, Mark Helfand, Mark |
author_sort | McDonagh, Marian S |
collection | PubMed |
description | The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described. |
format | Online Article Text |
id | pubmed-3532217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35322172013-01-03 Methods for the Drug Effectiveness Review Project McDonagh, Marian S Jonas, Daniel E Gartlehner, Gerald Little, Alison Peterson, Kim Carson, Susan Gibson, Mark Helfand, Mark BMC Med Res Methodol Correspondence The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described. BioMed Central 2012-09-12 /pmc/articles/PMC3532217/ /pubmed/22970848 http://dx.doi.org/10.1186/1471-2288-12-140 Text en Copyright ©2012 McDonagh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Correspondence McDonagh, Marian S Jonas, Daniel E Gartlehner, Gerald Little, Alison Peterson, Kim Carson, Susan Gibson, Mark Helfand, Mark Methods for the Drug Effectiveness Review Project |
title | Methods for the Drug Effectiveness Review Project |
title_full | Methods for the Drug Effectiveness Review Project |
title_fullStr | Methods for the Drug Effectiveness Review Project |
title_full_unstemmed | Methods for the Drug Effectiveness Review Project |
title_short | Methods for the Drug Effectiveness Review Project |
title_sort | methods for the drug effectiveness review project |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532217/ https://www.ncbi.nlm.nih.gov/pubmed/22970848 http://dx.doi.org/10.1186/1471-2288-12-140 |
work_keys_str_mv | AT mcdonaghmarians methodsforthedrugeffectivenessreviewproject AT jonasdaniele methodsforthedrugeffectivenessreviewproject AT gartlehnergerald methodsforthedrugeffectivenessreviewproject AT littlealison methodsforthedrugeffectivenessreviewproject AT petersonkim methodsforthedrugeffectivenessreviewproject AT carsonsusan methodsforthedrugeffectivenessreviewproject AT gibsonmark methodsforthedrugeffectivenessreviewproject AT helfandmark methodsforthedrugeffectivenessreviewproject |